systemic toxicity of local anesthetics (LAST) |
Termination of the TLA application |
Oxygenation, treatment of seizures (benzodiazepine), resuscitation (if necessary), administration of 20% lipid emulsion |
Continuous monitoring of vital parameters |
Neurological symptoms (seizures, unconsciousness, restlessness) |
Termination of the TLA application |
Oxygen supply, airway management, treatment of seizures (benzodiazepines), ECG monitoring if necessary |
Apnea following cerebral toxicity |
Termination of the TLA application |
Oxygen supply, resuscitation, continuous monitoring of vital parameters |
Cardiovascular symptoms (bradycardia, hypotension, cardiac arrhythmias) |
Termination of the TLA application |
Oxygenation, ECG monitoring |
Treatment according to the ECG findings |
Methemoglobinemia |
Termination of the TLA application |
Oxygenation |
Application of Methylene Blue |
treatment of seizures (benzodiazepines) |
Pneumothorax |
Use of non-ground needles in deep areas/ axilla |
Application of TLA in the axilla under sonographic control |
Continuous monitoring of vital parameters |
Chest x-ray |
Chest tube/ needle decompression if necessary |